Driving OTC Growth Through Innovation and Business Development

02.03.2017 | London (UK)
PLG - Pharmaceutical Licensing Group
Diapharm’s Dr. Guido Middeler will cover issues such as the European Union’s new regulations for medical devices during his presentation at the 2nd OTCToolbox / PLG conference. The Conference and Networking Event, which focusses exclusively on business development and innovation in the consumer healthcare and OTC market, will also feature presentations from Bayer Consumer Health, GlaxoSmithKline Consumer Healthcare, PGT Healthcare and Google Inc.

Jointly organised by the OTCToolbox website and the Pharmaceutical Licensing Group (PLG), the two-day international event will feature a programme of highly-respected speakers from the consumer healthcare/OTC industry, covering a wide range of topics:

  • Future Trends in Consumer Healthcare/OTC, George Fatouros (Bayer Consumer Health)
  • The Main Drivers of Growth, Andy Tisman (IMS Health)
  • Driving Growth: Innovation, Hélène Guillard (HRA Pharma) and Manfred Scheske (Infirst Healthcare)
  • Driving Growth: Digital Healthcare, Ryan Olohan (Google Inc.)
  • Driving Growth: Regulatory Strategies, Dr. Guido Middeler (Diapharm) and Helen Darracott (OTC Regulatory Consultant)
  • Driving Growth: Working with Retailers, Joachim Neukam (Steinbeis VMI)
  • Driving Growth: Innovation and Business Development, Kathleen Nitti and Robert Sarrazin (GlaxoSmithKline Consumer Healthcare)
  • Driving Growth: Business Development, Richard Learwood (PGT Healthcare)
  • Developing an OTC Business Using BD&L Resources – A Case Study, Dan Thomas (Alliance Pharmaceuticals)

The two-day event will offer opportunities for networking with an informal Networking Room available for one-to-one meetings, a Networking Dinner and a New Business Opportunity Hub.

Further information:

  1. Sprechen Sie uns an!
  2. Servicetelefon: +49 (0)251 609350 
    +43 1 5321606 

  3. E-Mail: info@diapharm.com

  4. Anrede*

Diese Webseite nutzt Cookies

Wir nutzen Cookies zur Verbesserung des Nutzererlebnisses. Indem Sie weiter auf dieser Webseite navigieren, erklären Sie sich damit einverstanden.